- 4-Week # shares sold: 2,296
- 12-Week # shares sold: 2.0 million
- 24-Week # shares sold: 2.2 million
Biogen spinoff Bioverativ proved healthy out of the gate, jumping from an open of $40 a share to a close of $47.35.
President-elect Donald Trump said the pharma industry was 'getting away with murder' during his first press conference as president-elect.